JPMorgan Chase
JPM
$313.49
+1.41%
JPMorgan Chase & Co. is a leading global financial services firm operating across three core segments: Consumer & Community Banking, Commercial & Investment Banking, and Asset & Wealth Management. It is the undisputed market leader in U.S. banking, boasting the largest balance sheet and holding the top global ranking in investment banking fees. The current investor narrative is dominated by the bank's resilience in a shifting interest rate environment, its ability to return capital to shareholders following annual stress tests, and the performance of its dominant investment banking franchise, particularly as the market for mega-cap tech IPOs, like the recent SpaceX deal, shows signs of reopening.…
JPM
JPMorgan Chase
$313.49
Related headlines
Investment Opinion: Should I buy JPM Today?
Rating & Thesis: JPMorgan is a Hold for existing investors, as its strong fundamentals are currently offset by weak technicals and sector headwinds, but it presents a compelling long-term Buy opportunity on further weakness. The core thesis is that the market is undervaluing the bank's unparalleled scale, cash flow, and capital return potential relative to near-term cyclical concerns, with analyst sentiment leaning bullish (Overweight/Outperform) ahead of the stress test catalyst.
Supporting Evidence: The valuation is reasonable, with a forward P/E of 13.20x implying modest growth expectations. Profitability is elite, evidenced by a 20.39% net margin and $100.87B in TTM free cash flow. The business is resilient, with diversified revenue streams across three major segments. Finally, a key near-term catalyst exists with the late June stress tests, which are expected to confirm the bank's capacity for shareholder returns.
Risks & Conditions: The two biggest risks are continued sector underperformance compressing the valuation multiple and a sharper-than-expected slowdown in revenue growth below 3%. This Hold rating would upgrade to a Buy if the stock approaches its 52-week low (~$260), offering a greater margin of safety, or if it sustains a breakout above key resistance at $337.25 on strong volume. It would downgrade to a Sell if revenue growth turns negative or credit costs spike unexpectedly. Relative to its own history and the quality of its franchise, the stock is currently fairly valued to slightly undervalued, but not compelling enough for new capital given the technical backdrop.
Sign up to view all
JPM 12-Month Price Forecast
The 12-month outlook for JPM is one of high-quality stagnation with a positive skew. The base case (55% probability) sees the stock muddling through with modest gains, supported by fundamentals but capped by sector sentiment. The bull case is credible (30%) given the powerful capital return catalyst and potential for multiple expansion if the investment banking cycle turns. The bear case risk (15%) is real but mitigated by the stock's distance from its 52-week low and the bank's robust capital position. The stance is neutral due to the conflict between strong fundamentals and weak price action. An upgrade to bullish would require a sustained breakout above $337.25 or clear evidence of revenue re-acceleration. A downgrade would be triggered by a breakdown below $260.31.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on JPMorgan Chase's 12-month outlook, with a consensus price target around $407.54 and implied upside of +30.0% versus the current price.
Average Target
$407.54
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$251 - $408
Analyst target range
Analyst coverage for JPMorgan is extensive, though the provided data shows only 5 analysts with detailed estimates, which is likely a subset of the broader coverage universe. The consensus sentiment leans bullish, as evidenced by recent institutional ratings from firms like Piper Sandler, Wells Fargo, and Barclays maintaining 'Overweight' or 'Outperform' stances. The average revenue estimate for the next period is $215.04 billion, with a tight range from $214.15 billion to $215.94 billion, indicating strong analyst conviction on the top-line outlook. The implied upside or downside to a specific price target cannot be calculated from the provided data, as an average target price is not given; however, the narrow range in revenue estimates and the prevalence of bullish ratings suggest a generally positive but measured consensus view on the stock's prospects, with catalysts like stress test results and capital return plans being key focal points.
Bulls vs Bears: JPM Investment Factors
The investment debate for JPMorgan centers on a clash between its undeniable fundamental strength and its recent weak price action. The bull case, supported by dominant market share, stellar cash generation, and an attractive forward valuation, currently holds stronger evidence from a long-term, fundamental perspective. However, the bear case is validated by the stock's persistent technical underperformance and decelerating growth metrics. The single most important tension is whether the market will soon reward the company's industry-leading quality and capital return potential, or if the stock will remain mired in sector-wide malaise and valuation compression. The resolution hinges on the upcoming stress test results and whether investment banking activity, signaled by the SpaceX IPO, can reignite top-line growth.
Bullish
- Dominant Scale & Market Leadership: JPMorgan is the undisputed leader in U.S. banking with a $4.9 trillion balance sheet and holds the top global ranking in investment banking fees with an 8.4% market share. This scale provides immense competitive advantages, operational efficiency, and a dominant position to capture market share, as evidenced by its leading role in the recent SpaceX IPO.
- Exceptional Cash Generation & Profitability: The firm generates an immense $100.87 billion in trailing twelve-month free cash flow and maintains a robust net margin of 20.39%. This strong profitability, coupled with a return on equity of 15.74%, demonstrates highly efficient capital use and provides a massive war chest for shareholder returns and strategic investments.
- Attractive Forward Valuation: The stock trades at a forward P/E of 13.20x, a discount to its trailing P/E of 15.75x and below its own historical peaks above 20x. This forward multiple is in line with or at a moderate premium to typical diversified bank valuations, suggesting the market is not pricing in aggressive growth expectations.
- Upcoming Capital Return Catalyst: The late June Federal Reserve stress test results are a key catalyst, with a freeze on stress capital buffers for 2026 already ensuring major banks can continue rewarding shareholders. JPMorgan's 14-year dividend growth streak and strong cash flow position it to potentially increase buybacks and dividends post-test.
Bearish
- Persistent Underperformance vs. Market: The stock has shown significant negative relative strength, underperforming the S&P 500 by -15.50% year-to-date and -11.73% over six months. Despite a beta of 1.02, this persistent weakness indicates it has been a source of sector laggardship, not just market correlation.
- Revenue & Earnings Growth Deceleration: Q4 2025 revenue growth slowed to 3.88% YoY, and net income of $13.03B declined sequentially from $14.39B in Q3 2025. This deceleration raises concerns about the bank's ability to maintain momentum in a potentially peaking interest rate environment.
- Technical Downtrend & Weak Momentum: The stock is in a pronounced downtrend, trading at $310.89, down 4.48% YTD and 1.32% over six months, sitting at ~92% of its 52-week range. It has retreated significantly from its 52-week high of $337.25, indicating a loss of bullish momentum and increased selling pressure.
- High Leverage & Interest Rate Sensitivity: With a debt-to-equity ratio of 2.60, the bank is highly leveraged, which is standard but amplifies risks in a downturn. Its performance is sensitive to interest rate shifts and credit cycles, as highlighted by recent sector rotation news punishing rate-sensitive names.
JPM Technical Analysis
The stock is in a pronounced downtrend from its recent highs, trading at $310.89, which represents a decline of 1.32% over the past six months and a year-to-date drop of 4.48%. It currently sits at approximately 92% of its 52-week range, having retreated significantly from its 52-week high of $337.25, indicating it is no longer in overextended territory but has given up considerable momentum. Recent short-term momentum shows a modest recovery, with a 0.48% gain over the past month and a 7.40% gain over three months, yet this positive short-term action is overshadowed by significant underperformance relative to the broader market, evidenced by a relative strength of -15.50 year-to-date and -11.73 over six months. The stock's beta of 1.02 suggests its volatility is nearly identical to the market, but its persistent negative relative strength indicates it has been a source of weakness within the financial sector. Key technical support is anchored at the 52-week low of $260.31, while immediate resistance lies at the recent highs near $337.25; a sustained break above this level would signal a resumption of the primary uptrend, whereas a breakdown below the 52-week low would confirm a more severe bearish phase.
Beta
1.00
1.00x market volatility
Max Drawdown
-15.5%
Largest decline past year
52-Week Range
$263-$337
Price range past year
Annual Return
+16.9%
Cumulative gain past year
| Period | JPM Return | S&P 500 |
|---|---|---|
| 1m | +2.8% | -0.1% |
| 3m | +10.6% | +11.4% |
| 6m | -1.6% | +8.2% |
| 1y | +16.9% | +22.7% |
| ytd | -3.7% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JPM Fundamental Analysis
Revenue growth has decelerated, with Q4 2025 revenue of $69.61 billion representing a 3.88% year-over-year increase, a slowdown from the stronger growth seen in prior quarters of 2025. Segment data shows balanced contributions, with Consumer & Community Banking and the Commercial & Investment Bank each generating approximately $19.4 billion in the latest period, while Asset and Wealth Management contributed $6.5 billion. The company remains highly profitable, reporting Q4 2025 net income of $13.03 billion and a robust net margin of 20.39%, though this represents a sequential decline from the $14.39 billion net income in Q3 2025. Gross margin for the quarter was 59.11%, and the trailing twelve-month free cash flow is an exceptionally strong $100.87 billion, demonstrating the firm's immense cash-generating ability. The balance sheet is leveraged but manageable for a major bank, with a debt-to-equity ratio of 2.60 and a current ratio of 0.52, which is typical for the banking industry where high leverage is standard; the stellar free cash flow and a return on equity of 15.74% underscore efficient use of capital and a strong capacity to fund operations and shareholder returns internally.
Quarterly Revenue
$69.6B
2025-12
Revenue YoY Growth
+0.03%
YoY Comparison
Gross Margin
+0.59%
Latest Quarter
Free Cash Flow
$100.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JPM Overvalued?
Given the positive net income of $13.03 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 15.75x and a forward PE of 13.20x, with the forward multiple's discount implying the market expects modest earnings growth ahead. Compared to typical industry averages for diversified banks (often in the low-to-mid teens), JPM's trailing PE of 15.75x represents a moderate premium, which may be justified by its industry-leading scale, profitability (20.39% net margin), and dominant market positions. Historically, the stock's own PE ratio has fluctuated significantly; the current trailing PE of 15.75x is below the 17.25x seen at the end of Q4 2025 and well below peaks above 20x in recent years, suggesting the stock is not at historical highs and may be pricing in a more conservative outlook relative to past optimism.
PE
15.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: JPMorgan's primary financial risk is its high leverage, with a debt-to-equity ratio of 2.60, which is inherent to the banking model but exposes the firm to amplified losses in a severe credit downturn. While profitability is strong, there is evidence of earnings volatility, with Q4 2025 net income of $13.03B representing a sequential decline of 9.5% from Q3. Furthermore, revenue growth has decelerated to 3.88% YoY, indicating potential challenges in sustaining top-line expansion. The bank's valuation also carries an implicit growth expectation; its forward P/E of 13.20x, while reasonable, still represents a premium that could compress if growth stalls further.
Market & Competitive Risks: The stock faces significant market risk from its persistent underperformance, with a year-to-date relative strength of -15.50% against the S&P 500, suggesting it is out of favor. Its beta of 1.02 means it moves with the market, but the negative alpha indicates specific sector headwinds. A key external threat is the risk of valuation compression, as its trailing P/E of 15.75x sits at a premium to many banking peers, leaving it vulnerable to sector rotation away from financials, as noted in recent news. Competitive disruption from fintech and a potential slowdown in the capital markets resurgence, despite the positive SpaceX IPO signal, are additional concerns.
Worst-Case Scenario: The worst-case scenario involves a combination of a sharp economic downturn triggering higher credit losses, a sustained decline in investment banking fees, and a sector-wide derating of bank stocks. This could lead to a significant earnings miss, a dividend freeze, and a rapid compression of the valuation premium. The realistic downside can be quantified by the 52-week low of $260.31, which represents a potential decline of approximately -16.3% from the current price of $310.89. A breach of this level could see the stock test lower supports, with losses potentially extending toward -20% to -25% in a severe bear market for financials.
FAQ
The key risks are: 1) Macroeconomic & Credit Risk: A recession would increase loan losses; the bank's high leverage (D/E of 2.60) amplifies this. 2) Interest Rate & Sector Risk: Its performance is tied to the interest rate cycle and broader financial sector sentiment, evidenced by its -15.50% YTD relative strength. 3) Operational Risk: Revenue growth has decelerated to 3.88% YoY, and expenses have been rising, posing a margin risk. 4) Valuation Risk: Its premium multiple could compress if growth stalls or sector rotation persists. The macroeconomic risk is currently the most severe given the uncertain outlook.
The 12-month forecast presents three scenarios. The base case (55% probability) sees the stock trading between $310 and $337, grinding higher on steady execution and capital returns. The bull case (30% probability) targets $337 to $360, driven by a strong stress test outcome and a vibrant investment banking rebound. The bear case (15% probability) risks a drop to the $260-$295 range if credit concerns mount and sector outflows continue. The base case is most likely, anchored by the assumption that the company's fundamental strength will eventually outweigh near-term technical weakness, especially post-stress tests.
JPM stock is fairly valued to slightly undervalued relative to its own quality but carries a premium versus the banking sector. Its trailing P/E of 15.75x is above typical diversified bank averages (low-to-mid teens), justified by its superior profitability (20.39% net margin) and market position. However, its forward P/E of 13.20x suggests the market expects only modest growth. Compared to its own historical P/E peaks above 20x, the current multiple is conservative. The valuation implies the market is paying for stability and capital return, not for explosive growth.
JPM is a good stock to buy for long-term investors seeking quality and income, but timing is crucial. At its current price of $310.89 and a forward P/E of 13.20x, it is fairly valued, not deeply undervalued. The ~16% potential downside to its 52-week low of $260.31 presents a more attractive entry point. For new money, it is a 'Hold and wait for a better price' or a 'Buy in stages on weakness.' The strong bullish case rests on its market leadership and capital return potential, making it a core holding for patient investors.
JPM is unequivocally suitable for long-term investment (3-5 year minimum horizon). Its low dividend yield (1.85%) and market-beta volatility (beta 1.02) make it a poor short-term trading vehicle, especially given its recent weak momentum. The investment thesis is based on compounding capital returns, dividend growth, and the durability of its competitive advantages over time. Short-term traders would be better served by more volatile, catalyst-driven names. For long-term investors, JPM serves as a foundational financial sector holding to be accumulated during periods of sector pessimism.